Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 17,280,330 | 15,279,540 | 16,285,250 | 13,745,920 | 13,177,620 |
| Cost of Goods | 7,774,239 | 6,820,501 | 7,748,382 | 6,238,646 | 5,977,180 |
| Gross Profit | 9,506,094 | 8,459,036 | 8,536,864 | 7,507,270 | 7,200,440 |
| Operating Expenses | 6,532,320 | 5,307,590 | 6,643,210 | 4,107,340 | 4,051,240 |
| Operating Income | 2,974,012 | 3,151,944 | 1,894,032 | 3,400,575 | 3,149,380 |
| Interest Expense | 146,365 | 205,479 | 234,759 | 23,221 | 81,760 |
| Other Income | 559,504 | 374,522 | 223,875 | 439,053 | 329,260 |
| Pre-tax Income | 3,387,151 | 3,320,987 | 1,883,148 | 3,816,407 | 3,396,880 |
| Income Tax | 882,426 | 773,982 | 332,758 | 1,030,430 | 951,120 |
| Net Income Continuous | 2,504,725 | 2,547,005 | 1,550,390 | 2,785,977 | 2,445,759 |
| Net Income Discontinuous | 248,508 | 246,698 | N/A | N/A | 0 |
| Net Income | $2,753,233 | $2,793,703 | $1,550,390 | $2,785,977 | $2,445,750 |
| EPS Basic Total Ops | 1.76 | 1.79 | 1.00 | 1.80 | 1.59 |
| EPS Basic Continuous Ops | 1.60 | 1.63 | 1.00 | 1.80 | 1.59 |
| EPS Basic Discontinuous Ops | 0.16 | 0.16 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 1.75 | 1.78 | 0.99 | 1.78 | 1.57 |
| EPS Diluted Continuous Ops | 1.59 | 1.62 | 0.99 | 1.78 | 1.57 |
| EPS Diluted Discontinuous Ops | 0.16 | 0.16 | N/A | N/A | N/A |
| EBITDA(a) | $4,101,451 | $4,195,566 | $3,062,050 | $4,228,006 | $3,977,380 |